Results 1-10 out of 116
-
Interim Results
20 May 2009 -
Commencement of Clinical Study of Cogane™ in Patients with Parkinson’s disease
20 April 2009 -
Interim Management Statement for 3 months ended 31 December 2008
17 February 2009Phytopharm plc (PYM: London Stock Exchange) (”Phytopharm” or the “Company”) is today issuing its Interim Management Statement (”IMS”) which relates to the three month period from 1 October 2008 to 31 December 2008 and contains information up to the date of publication of this IMS.
-
Unilever returns rights to Hoodia extract
12 December 2008 -
Preliminary Results for the period ended 30 September 2008
27 November 2008 -
Update
14 November 2008GODMANCHESTER, Cambridgeshire, U.K. (14 November 2008) – Phytopharm plc (PYM: London Stock Exchange) (“Phytopharm” or the “Company”) today provides the following update
-
Board Changes
13 November 2008GODMANCHESTER, Cambridgeshire, U.K.– The Board of Phytopharm plc (PYM: London Stock Exchange) (“Phytopharm” or the “Company”) today announces that the Company has received notice of termination of employment contract from Daryl Rees, Chief Executive Officer, and Piers Morgan, Chief Financial Officer. They cease to be Directors of the Company with immediate effect.
-
Interim Management Statement for 3 months ended 30 June 2008
03 July 2008Phytopharm plc (PYM: London Stock Exchange) (“Phytopharm” or the “Company”) is today issuing its Interim Management Statement (“IMS”) which relates to the three month period from 1 April 2008 to 30 June 2008 and contains information up to the date of publication of this IMS.
-
Launch of Phytopica® in Hong Kong
11 June 2008Phytopharm plc (PYM: London Stock Exchange) (“Phytopharm” or the “Company”) announces today the launch of Phytopica® in Hong Kong by its partner, Intervet/Schering-Plough Animal Health.
-
Interim Results
29 May 2008